Taipei Exchange - Delayed Quote TWD
Sunmax Biotechnology Co., Ltd. (4728.TWO)
448.00
+21.00
+(4.92%)
At close: 1:30:16 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
949,177
949,177
768,186
1,400,074
1,035,659
Cost of Revenue
214,024
214,024
165,073
207,274
141,212
Gross Profit
735,153
735,153
603,113
1,192,800
894,447
Operating Expense
195,637
195,637
177,325
425,194
526,834
Operating Income
539,516
539,516
425,788
767,606
367,613
Net Non Operating Interest Income Expense
1,338
1,338
1,509
4,806
556
Pretax Income
838,694
838,694
792,415
777,178
357,486
Tax Provision
159,289
159,289
166,707
243,346
111,844
Net Income Common Stockholders
679,405
679,405
625,708
533,832
245,642
Diluted NI Available to Com Stockholders
679,405
679,405
625,708
533,832
245,642
Basic EPS
12.47
--
11.49
9.80
4.51
Diluted EPS
12.46
--
11.47
9.79
4.51
Basic Average Shares
54,463
--
54,463
54,463
54,463
Diluted Average Shares
54,536
--
54,535
54,539
54,524
Total Expenses
409,661
409,661
342,398
632,468
668,046
Net Income from Continuing & Discontinued Operation
679,405
679,405
625,708
533,832
245,642
Normalized Income
643,573.76
643,573.76
578,889.76
533,250.90
247,251.28
Interest Income
2,784
2,784
2,567
6,151
3,362
Interest Expense
1,446
1,446
1,058
1,345
2,806
Net Interest Income
1,338
1,338
1,509
4,806
556
EBIT
840,140
840,140
793,473
778,523
360,292
EBITDA
911,188
911,188
830,708
836,673
416,055
Reconciled Cost of Revenue
214,024
214,024
165,073
207,274
141,212
Reconciled Depreciation
71,048
71,048
37,235
58,150
55,763
Net Income from Continuing Operation Net Minority Interest
679,405
679,405
625,708
533,832
245,642
Total Unusual Items Excluding Goodwill
44,232
44,232
59,292
846
-2,342
Total Unusual Items
44,232
44,232
59,292
846
-2,342
Normalized EBITDA
866,956
866,956
771,416
835,827
418,397
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
8,400.76
8,400.76
12,473.76
264.90
-732.72
12/31/2021 - 1/10/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6535.TWO Lumosa Therapeutics Co., Ltd.
157.00
+1.29%
4162.TWO PharmaEngine, Inc.
87.90
+0.23%
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
89.40
+0.90%
6919.TW CALIWAY BIOPHARMACEUTICALS CO L
612.00
+0.66%
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
84.10
+1.45%
6712.TWO Ever Supreme Bio Technology Co., Ltd
167.50
+0.30%
4726.TWO Mycenax Biotech Inc.
31.00
+1.47%
6733.TWO BioGend Therapeutics Co., Ltd.
26.25
0.00%
8279.TWO Syngen Biotech Co.,Ltd.
123.00
0.00%
6461.TWO Intech Biopharm Corporation
17.75
+2.01%